Ware Grove
Analyst · First Analysis
Thank Steve, and good morning, everyone. As we usually do, I want to take a few minutes to run through the numbers released this morning for the third quarter and the year-to-date results ended September 30, 2015. As a reminder, as we talk about results this year compared with last year we will make an adjustment to the 2014 results to account for the sale of our Miami financial services office, which was sold last year in the fourth quarter. And thanks to the many CBIZ associates who are working hard to serve clients in our markets across the U.S. We are pleased to report strong results for the quarter and for the nine months this year compared with last year. For the third quarter ended September 30, 2015 adjusting for the sale of the Miami office, total revenue grew by 4.7% with the same unit revenue growing by 2.8% compared with prior year. We are pleased to report a significant improvement from pretax margin so that pretax earnings increased approximately 40% in the third quarter this year compared with a year ago. For the nine months, total revenue increased by 5.1% when you adjust for the sale of Miami office with an improvement in pretax margin of 70 basis points resulting in an increase in pretax income of 12.5% for the nine months this year compared with a year ago. We are successfully leveraging our G&A infrastructure and you also know the reduction in interest expense that is occurring as a result of the early note repurchases that have occurred in late 2014 and throughout the second quarter of 2015. Now within our financial services group when you adjust for the sale of the Miami office, total revenue grew by 3.5% for the quarter and grew by 3% for the nine months this year compared with a year ago. Same unit revenue growth was very similar, up 3.5% for the quarter and up 2.8% for the nine months this year. We are continuing to see very strong growth in our healthcare consulting business within financial services. Turning to employee services, total revenue grew by 7.7% in the third quarter and grew by 10.4% for the nine months this year compared with last year. Same unit revenue growth was 1.9% in the third quarter and was 1.6% for the nine months this year compared with last year. We are continuing to record growth and employee group benefits property and casualty and human capital consulting and recruiting with continued weakness in the life insurance area, eliminating the impact of the life insurance area, the organic or same unit revenue growth was up 2.5% for the nine months this year. As we have commented over the past three quarters, due to the accounting related to the convertible note and the earlier retirement transactions completed earlier, our share count have been difficult to predict this year. Our weighted average share count for the nine months ended September 30, 2015 includes 1.3 million share equivalence calculated on the 48.4 million note balance still outstanding on that date. Once the notes are paid in full, the share equivalent calculation will no longer apply and this will not be included in the share count calculation at year end 2015. The weighted average share count has also been impacted by the issuance of 5.1 million shares in connection with the early retirement of $49.3 million of the notes that occurred in the second quarter of this year. To help neutralize the impact of issuing these additional shares, we have continued to be active with share repurchases and we repurchased approximately 1.9 million shares in the third quarter and then for the nine months we have repurchased a total of approximately 3.8 million shares to date. As a result of these factors on share count, we reported earnings per share of $0.68 for the nine months this year compared to $0.62 for the nine months a year ago, an increase of 9.7%. Eliminating the impact of the 1.3 million share equivalence calculated on the convertible note at September 30, the adjusted EPS for the nine months this year was $0.70 and that compares with an adjusted $0.64 a year ago. Extending the full year impact of these transactions and assuming no further share repurchase activity in the fourth quarter this year, we are projecting a full year weighted average share count of approximately 51.5 million shares at December 31, 2015. Now we have closed two acquisitions so far this year. Through September 30 this year we used $15.7 million for acquisition related activities including earn out payments on prior year acquisitions. Future acquisition related payments that are scheduled include an additional $5.9 million this year, $10.7 million scheduled in 2016, $6.2 million forecasted in 2017 and another $1.5 million in 2018. Now as I mentioned earlier in connection with a 3.8 million shares repurchased this year we also used $35.2 million for this activity through September 30 this year. Capital spending for the nine months this year has been $6.3 million with $900,000 used in the third quarter. As I commented during our second quarter conference call, the good share of the capital spending this year was in connection with a 100,000 square foot office move and relocation in Kansas City that involved about 450 CBIZ Associates. We expect full year capital spending to be about $7 million this year. Bad debt expense was 79 basis points on revenue for the nine months ended September 30 this year and that compares with 65 basis points for the nine months a year ago. Days sales outstanding on receivables stood at 85 days this year at September 30 compared with 86 days at this point a year ago. Our effective tax rate for the nine months this year was 41.2%, essentially the same rate as a year ago. And for the full year of 2015, we continue to expect an effective tax of approximately 40%. Now turning to our financing activities, as we are currently nearing the conclusion of the settlement period for our 4.875% convertible notes that matured on October 1, I want to take a few minutes to give you an update and what this means for CBIZ as we refinance these notes. As a reminder, through a series of privately negotiated transactions, we have already retired $81.6 million of the notes earlier in 2014 and again in 2015, so the remaining balance at this time is $48.4 million. The settlement period runs 20 trading days beginning October 5 and running through the end of October 30. And the entire balance will be paid in cash on November 4 including any premium above par. The notes calculate a premium over par as the share price exceeds $7.41. So at this time 17 days through the 20 days settlement period it appears that a total payment of approximately $71 million to $72 million will be due on November 4 for the $48.4 million par value plus the conversion premium above par of approximately $23 million to $24 million. Now while this premium over par clearly results in a higher cost of debt to CBIZ it was worth noting that this premium is a result of the increase in the share value of approximately 100% over the five year life of the notes. As a reminder, on the date of issue five years ago in 2010 the share price was $5.49. And that compares with a current share price that’s in excess of $11 today. As we have said many times since the convertible note was initially issued settling the notes at a premium over par is a nice problem to have, as this really means the CBIZ shareholder has enjoyed an attractive return during this time. We have a $400 million unsecured credit facility in place and the current balance outstanding is approximately $150 million. Currently unutilized borrowing capacity is about $150 million so there is sufficient capacity to make the cash payment on November 4 and we still have plenty of capacity to continue an active acquisition program going forward. We also have excess capacity continue to take an opportunistic approach towards future share repurchases, if we deem those to be inappropriate use of our capital. Our goal is to maintain a stable share count at approximately 50 million shares, but our first priority in our use of capital continues to be focused on strategic acquisitions. So to sum up, with the convertible note maturing October 1st and scheduled for payment on November 4th, we will refinance this with lower cost debt. And this will also eliminate a level of complexity that is associated with the accounting for the convertible note. The interest rate on the convertible note was being recorded as 7.5% and as we refinance the current incremental borrowing rate on our bank line of credit is under 3.0%. On top of that, we recently transacted an interest rate swap that will effectively fix the rate on a $25 million portion of this borrowing at 2.8% for the next five years. Again, to sum up, we are happy with the results reported for the nine months ended September 30, 2015. And we continue to look for full year revenue growth in the 5% to 7% range with earnings per share growth in the range of 12% to 15% compared with an adjusted 2014 earnings per share of $0.61. And that assumes the cost of share count this year compared with last year. Cash flow continues to be strong and we continue to project EBITDA growth this year in a range of 8% to 10% over 2014. So with these comments, I'll conclude and I'll turn it back over to Steve.